:: Library Catalog

Buchumschlag

Gespeichert in:

Bibliographische Detailangaben
1. Verfasser:	Iskandar Idris
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	Diabetes, Obesity and Metabolism Now
Online-Zugang:	https://dom-pubs.pericles-prod.literatumonline.com/doi/10.1002/doi2.70002
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Appropriate timing of exercise for adults with obesity including those with type 2 diabetes
von: Iskandar Idris
Veröffentlicht: (2024)

Precision medicine approach to detect obese people who are at high risk of developing diabetes
von: Iskandar Idris
Veröffentlicht: (2024)

Extension study from DIRECT showed ongoing remission rate from type 2 diabetes in some patient following very low calorie diet at 5 years
von: Iskandar Idris
Veröffentlicht: (2024)

Epigenetic changes shown to cause type 2 diabetes
von: Iskandar Idris
Veröffentlicht: (2024)

Glucagon like peptide‐1 (GLP‐1) therapy is associated with reduced risk of developing cirrhosis and liver cancer in people with type 2 diabetes with chronic liver disease
von: Iskandar Idris
Veröffentlicht: (2024)

Hybrid closed‐loop therapy significantly improved maternal glucose control during pregnancy complicated by type 1 diabetes
von: Iskandar Idris
Veröffentlicht: (2024)

Fenofibrate shown to reduce progression of diabetic retinopathy
von: Iskandar Idris
Veröffentlicht: (2024)

Adults who are overweight or obese may experience greater pain intensity compared with normal weight individuals?
von: Iskandar Idris
Veröffentlicht: (2024)

Potential role of glucagon like peptide (GLP)‐1 receptor agonist to reduce risk of colorectal cancer?
von: Iskandar Idris
Veröffentlicht: (2024)

Real world study provided reassurance of the safety of GLP‐1 therapy on mental health and suicide risk
von: Iskandar Idris
Veröffentlicht: (2024)

Increasing excess to weight loss injection shown to save thousands of lives a year
von: Iskandar Idris
Veröffentlicht: (2024)

The glucagon like peptide‐1 linked to nonarteritic anterior ischemic optic neuropathy
von: Iskandar Idris
Veröffentlicht: (2024)

Tirzepatide shown to be effective at reducing sleep disturbances in patients with obstructive sleep apnoea
von: Iskandar Idris
Veröffentlicht: (2024)

Tirzepatide shown to improve clinical outcomes for patients with heart failure with preserved ejection fraction (HFpEF) and obesity
von: Iskandar Idris
Veröffentlicht: (2024)

The US Food and Drug administration has approved resmetirom as the first drug to treat metabolic dysfunction‐associated steatohepatitis (MASH)
von: Iskandar Idris
Veröffentlicht: (2024)

Potential new therapies to preserve lean muscle mass loss when used in combination with glucagon‐like peptide 1 (GLP‐1) receptor agonist being studied
von: Iskandar Idris
Veröffentlicht: (2024)

Real world data showed that the dual GLP gip agonist, Tirzepatide is associated with lower mortality, cardiovascular events and adverse kidney events compared with GLP‐1 analogue
von: Iskandar Idris
Veröffentlicht: (2024)

Increased expression of the protein Kallistatin after weight loss induces beneficial metabolic effects: A potential new therapeutic target?
von: Iskandar Idris
Veröffentlicht: (2024)

Issue Information
Veröffentlicht: (2024)

Issue Information
Veröffentlicht: (2024)

Issue Information
Veröffentlicht: (2024)

Issue Information
Veröffentlicht: (2024)

Issue Information
Veröffentlicht: (2024)

Issue Information
Veröffentlicht: (2024)

Issue Information
Veröffentlicht: (2024)

Issue Information
Veröffentlicht: (2024)

The latest evidence and guidance in lifestyle and surgical interventions to achieve weight loss in people with overweight or obesity
von: Iskandar Idris, et al.
Veröffentlicht: (2025)

Sex as a modifier of genetic risk for type 1 diabetes
von: Hui‐Qi Qu, et al.
Veröffentlicht: (2025)

Type 2 diabetes genetic risk and incident diabetes across diabetes risk enhancers
von: Filipe A. Moura, et al.
Veröffentlicht: (2024)

Effect of exercise on plasma insulin levels in individuals with type 1 diabetes: A systematic review and meta‐analysis
von: Lum Kastrati, et al.
Veröffentlicht: (2024)

Genomic risk prediction for type 2 diabetes in Australian individuals aged 70 years and older
von: Chenglong Yu, et al.
Veröffentlicht: (2025)

Efficacy of a low‐carbohydrate diet combined with exercise on glycemic control and metabolic health in type 2 diabetes mellitus: A systematic review and meta‐analysis
von: Ye He, et al.
Veröffentlicht: (2025)

Potential benefits of hybrid closed‐loop systems for managing moderate‐ to high‐risk individuals with type 1 diabetes during Ramadan fasting
von: Abdullah M. Alguwaihes, et al.
Veröffentlicht: (2025)

Effect of tirzepatide on the risk of diabetic retinopathy in type 2 diabetes
von: Djordje S. Popovic, et al.
Veröffentlicht: (2024)

Postnatal glycaemic outcomes in women with high‐risk gestational diabetes: Identifying key predictors for early intervention
von: Pei Chia Eng, et al.
Veröffentlicht: (2024)

Smoking timing, genetic susceptibility and the risk of incident type 2 diabetes: A cohort study from the UK Biobank
von: Ying Hu, et al.
Veröffentlicht: (2024)

Cognitive reserve, genetic risk, and lifestyle in the incidence and progression of type 2 diabetes: A large community‐based longitudinal study
von: Shaojie Han, et al.
Veröffentlicht: (2025)

Association between accelerometer‐measured physical activity, genetic risk, and incident type 2 diabetes: A prospective cohort study
von: Yang Pan, et al.
Veröffentlicht: (2025)

Accelerated onset of diabetes in non‐obese diabetic mice fed a refined high‐fat diet
von: Heidi M. Batdorf, et al.
Veröffentlicht: (2024)

Lifetime and 10‐year cardiovascular risk prediction in individuals with type 1 diabetes: The LIFE‐T1D model
von: Marga A. G. Helmink, et al.
Veröffentlicht: (2024)